Proposed Data Collection Submitted for Public Comment and Recommendations, 76592-76594 [2016-26500]
Download as PDF
<![CDATA[
76592
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 1:00 p.m.–5:00 p.m.
EST, December 13, 2016.
Place: This meeting will be held via
Teleconference and web access.
Teleconference and web access login
information is as follows:
Toll-Free Telephone: 1–888–566–
6510, Participant passcode: 3895011.
Net Conference and Web Url: https://
www.mymeetings.com/nc/join/.
Conference number: PWXW1545545,
Audience passcode: 3895011.
Participants can join the event
directly at: https://
www.mymeetings.com/nc/join.php?
i=PWXW1545545&p=3895011&t=c.
WebEx Required Download:
Participants must have the WebEx Event
Manager installed prior to joining the
web portion of the meeting.
Status: Open to the public, limited
only by the audio phone lines and net
conference access available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters for Discussion: The agenda
will include discussions on the current
and emerging topics related to breast
cancer in young women. These will
include public health communication,
breast cancer in young women digital
and social media campaigns, and CDC
updates. Committee workgroups will
report findings to the committee.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 3
business days in advance at https://
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
www.cdc.gov/cancer/breast/what_cdc_
is_doing/meetings.htm. Please complete
all the required fields before submitting
your registration and submit no later
than December 8, 2016.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 5770 Buford Hwy, NE.,
Mailstop K52, Atlanta, Georgia 30341,
Telephone (770) 488–4518, Fax (770)
488–4760. Email: acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–26569 Filed 11–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17BZ]; Docket No. CDC–2016–
0104]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Project
Pride.’’ This project is funded by CDC
at 12 health departments in the United
States. The health departments will
report standardized program monitoring
and evaluation (M&E) data to CDC. CDC
is requesting approval to collect
standardized HIV prevention program
evaluation data from funded health
departments.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Written comments must be
received on or before January 3, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0104 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
DATES:
E:\FR\FM\03NON1.SGM
03NON1
76593
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Project PrIDE—New—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
State, local and territorial health
departments in the U.S. are
implementing high impact HIV
prevention programs to reduce new HIV
infections among populations of gay,
bisexual, and other men who have sex
with men (MSM) and transgender
persons. Additional effort is needed to
realize the benefits of new prevention
strategies that have the potential to
significantly reduce new HIV infections
and increase viral suppression among
MSM and transgender persons.
Pre-exposure prophylaxis (PrEP) is a
potent new prevention tool for MSM
without HIV but who are at substantial
risk of acquiring HIV infection. The
daily use of oral, antiretroviral
medication (PrEP) with co-formulated
tenofovir disoproxil fumarate and
emtricitabine (marketed as Truvada®) is
proven to significantly reduce the risk of
HIV acquisition among sexually active
adults. In July 2012, the US Food and
Drug Administration approved an HIV
prevention indication for Truvada, and
in May 2014 CDC published Public
Health Service clinical practice
guidelines for provision of PrEP to
persons at substantial risk of HIV
acquisition through sexual or injection
routes of transmission as part of a
package of HIV prevention clinical
services. It is critical for health
departments to address barriers to and
facilitate broader awareness, support
and capacity for the scale-up of PrEP
services for MSM and transgender
persons at high risk for HIV infection,
particularly persons of color,
recognizing that the population with the
highest incidence of HIV in the U.S. is
young African American MSM.
Another potent prevention tool
involves antiretroviral medication to
suppress HIV–1 viral load, improve
health outcomes and reduce
transmission risk among people living
with HIV (PLWH). The importance of
antiretroviral treatment has increased
focus on interventions and public health
strategies designed to link, engage and
re-engage persons living with HIV in
health care, with the ultimate outcome
of suppressing HIV viral load,
decreasing morbidity and increasing
survival. To increase viral suppression,
more people who are diagnosed with
HIV will need to be retained in HIV
medical care and receive antiretroviral
treatment. There is a need for health
departments to implement public health
strategies for improving linkage,
engagement and re-engagement of MSM
and transgender persons who are not in
care.
Data to Care is a public health strategy
for identifying these individuals. Data to
Care is based on the use of surveillance
data to intervene directly in disease
control. Data to Care programs use
laboratory reports received by a health
department’s HIV surveillance program,
and a range of other data sources as
markers of HIV care, and analyze these
reports to confidentially identify HIVdiagnosed individuals who are not
engaged in HIV medical care or have not
achieved viral suppression. Several state
health departments have taken steps
toward initiating a Data to Care
program, and a few have reported
successful implementation of Data to
Care activities. It is important that these
efforts be expanded and that other state,
local and territorial health departments
scale up and implement this promising
public health strategy to improve
outcomes along the HIV continuum of
care and prevent new HIV infections.
The purpose of this project is to
support 12 health departments in the
United States to implement PrEP and
Data to Care demonstration projects for
200 clients annually, prioritizing MSM
and transgender persons at high risk of
HIV infection, particularly persons of
color.
Health departments that are involved
in this project will be required to
prioritize their services to these
populations. Services may also be
provided for persons at substantial risk
for HIV (for PrEP) or persons who have
HIV and are not virally suppressed or
have ongoing risk behavior (for Data to
Care) who are not MSM or transgender.
CDC HIV program grantees will
collect, enter or upload, and report
budget data, information on the HIV
prevention and care services, and client
demographic characteristics with an
estimated of 1,104 burden hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average burden
per response
(in hours)
Total burden
hours
Form name
Clients ...........................................
Health Departments ......................
Health Departments ......................
Data Elements ..............................
Data Management ........................
Performance Progress Report .....
2,400
12
12
1
2
1
25/60
20/60
8
1,000
8
96
Total .......................................
mstockstill on DSK3G9T082PROD with NOTICES
Type of respondents
.......................................................
..........................
..........................
..........................
1,104
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\03NON1.SGM
03NON1
76594
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–26500 Filed 11–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates: 8:15 a.m.–5:00 p.m.,
Mountain Time, November 30, 2016;
8:15 a.m.–10:00 a.m., Mountain Time,
December 1, 2016.
Public Comment Time and Date: 5:00
p.m.–6:00 p.m.*, Mountain Time,
November 30, 2016.
* Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Place: Hilton Santa Fe Historic Plaza,
100 Sandoval Street, Santa Fe, New
Mexico 87501; Phone: (505) 986–6416;
Fax: (505) 986–6439.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people. The public is also welcome to
listen to the meeting by joining the
teleconference at USA toll-free, dial-in
number, 1–866–659–0537 and the pass
code is 9933701.
Live Meeting Connection: https://
www.livemeeting.com/cc/cdc/join?id=
Z9K2DF&role=attend&pw=ABRWH;
Meeting ID: Z9K2DF; Entry Code:
ABRWH.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; Dose
Reconstruction Report to the Secretary;
SEC Petitions Update; Site Profile
review for Hooker Electrochemical
(Niagara, New York); SEC petitions for:
Area IV of Santa Susana Field
Laboratory (1965–1988; Ventura County,
California), Carborundum Company
(1943–1976; Niagara Falls, New York),
Savannah River Site (1973–2007; Aiken,
South Carolina), and Los Alamos
National Laboratory (1996–2005; Los
Alamos, New Mexico); and Board Work
Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted to the contact person below
well in advance of the meeting. Any
written comments received will be
provided at the meeting in accordance
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
with the redaction policy provided
below.
Policy on Redaction of Board Meeting
Transcripts (Public Comment):
(1) If a person making a comment
gives his or her personal information, no
attempt will be made to redact the
name; however, NIOSH will redact
other personally identifiable
information, such as contact
information, social security numbers,
case numbers, etc., of the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Pages 76592-76594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26500]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-17BZ]; Docket No. CDC-2016-0104]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project entitled ``Project Pride.'' This project
is funded by CDC at 12 health departments in the United States. The
health departments will report standardized program monitoring and
evaluation (M&E) data to CDC. CDC is requesting approval to collect
standardized HIV prevention program evaluation data from funded health
departments.
DATES: Written comments must be received on or before January 3, 2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0104 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires Federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be
[[Page 76593]]
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information.
Proposed Project
Project PrIDE--New--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
State, local and territorial health departments in the U.S. are
implementing high impact HIV prevention programs to reduce new HIV
infections among populations of gay, bisexual, and other men who have
sex with men (MSM) and transgender persons. Additional effort is needed
to realize the benefits of new prevention strategies that have the
potential to significantly reduce new HIV infections and increase viral
suppression among MSM and transgender persons.
Pre-exposure prophylaxis (PrEP) is a potent new prevention tool for
MSM without HIV but who are at substantial risk of acquiring HIV
infection. The daily use of oral, antiretroviral medication (PrEP) with
co-formulated tenofovir disoproxil fumarate and emtricitabine (marketed
as Truvada[supreg]) is proven to significantly reduce the risk of HIV
acquisition among sexually active adults. In July 2012, the US Food and
Drug Administration approved an HIV prevention indication for Truvada,
and in May 2014 CDC published Public Health Service clinical practice
guidelines for provision of PrEP to persons at substantial risk of HIV
acquisition through sexual or injection routes of transmission as part
of a package of HIV prevention clinical services. It is critical for
health departments to address barriers to and facilitate broader
awareness, support and capacity for the scale-up of PrEP services for
MSM and transgender persons at high risk for HIV infection,
particularly persons of color, recognizing that the population with the
highest incidence of HIV in the U.S. is young African American MSM.
Another potent prevention tool involves antiretroviral medication
to suppress HIV-1 viral load, improve health outcomes and reduce
transmission risk among people living with HIV (PLWH). The importance
of antiretroviral treatment has increased focus on interventions and
public health strategies designed to link, engage and re-engage persons
living with HIV in health care, with the ultimate outcome of
suppressing HIV viral load, decreasing morbidity and increasing
survival. To increase viral suppression, more people who are diagnosed
with HIV will need to be retained in HIV medical care and receive
antiretroviral treatment. There is a need for health departments to
implement public health strategies for improving linkage, engagement
and re-engagement of MSM and transgender persons who are not in care.
Data to Care is a public health strategy for identifying these
individuals. Data to Care is based on the use of surveillance data to
intervene directly in disease control. Data to Care programs use
laboratory reports received by a health department's HIV surveillance
program, and a range of other data sources as markers of HIV care, and
analyze these reports to confidentially identify HIV-diagnosed
individuals who are not engaged in HIV medical care or have not
achieved viral suppression. Several state health departments have taken
steps toward initiating a Data to Care program, and a few have reported
successful implementation of Data to Care activities. It is important
that these efforts be expanded and that other state, local and
territorial health departments scale up and implement this promising
public health strategy to improve outcomes along the HIV continuum of
care and prevent new HIV infections.
The purpose of this project is to support 12 health departments in
the United States to implement PrEP and Data to Care demonstration
projects for 200 clients annually, prioritizing MSM and transgender
persons at high risk of HIV infection, particularly persons of color.
Health departments that are involved in this project will be
required to prioritize their services to these populations. Services
may also be provided for persons at substantial risk for HIV (for PrEP)
or persons who have HIV and are not virally suppressed or have ongoing
risk behavior (for Data to Care) who are not MSM or transgender.
CDC HIV program grantees will collect, enter or upload, and report
budget data, information on the HIV prevention and care services, and
client demographic characteristics with an estimated of 1,104 burden
hours.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Clients......................................... Data Elements..................... 2,400 1 25/60 1,000
Health Departments.............................. Data Management................... 12 2 20/60 8
Health Departments.............................. Performance Progress Report....... 12 1 8 96
-------------------------------------------------------------------
Total....................................... .................................. ............... ............... ............... 1,104
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 76594]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-26500 Filed 11-2-16; 8:45 am]
BILLING CODE 4163-18-P
